Latest filing published 30 Apr 2026 for Zylox-Tonbridge Medical Technology Co., Ltd., €3.7M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Li Zheng: trading record in brief
This profile gathers the share dealings of Li Zheng in Zylox-Tonbridge Medical Technology Co., Ltd., where the filings describe the role as chief executive. We count 5 filings; the first trade dates from 2 April 2026 and the latest from 29 April 2026.
No open-market purchase appears, only 1 sale worth €7.8M.
Most recently, on 30 April 2026, the filings show a transaction worth €3.7M in Zylox-Tonbridge Medical Technology Co., Ltd. The median gap between a trade and its publication by HKEX is 4 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to Li Zheng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 160,000 shares0.51% mcap14.5% of flowShareXHKGHKEX:DA20260430E00222
- 50,000 shares0.16% mcap4.5% of flowShareXHKGHKEX:DA20260430E00230
- 540,000 shares1.74% mcap49.9% of flowShareXHKGHKEX:DA20260420E00393
- 3,420,000 shares@ HK$21.001.09% mcap100.0% of flowShareXHKGHKEX:DA20260410E00497
- 11,476,617 sharesShareXHKGHKEX:DA20260410E00211
5 of 5 declarations